Skip to main content
Erschienen in: Journal of Cancer Survivorship 2/2016

01.04.2016

The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study

verfasst von: Allan “Ben” Smith, Phyllis Butow, Ian Olver, Tim Luckett, Peter Grimison, Guy C. Toner, Martin R Stockler, Elizabeth Hovey, John Stubbs, Sandra Turner, George Hruby, Howard Gurney, Mahmood Alam, Keith Cox, Madeleine T. King

Erschienen in: Journal of Cancer Survivorship | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aimed to establish the prevalence, severity, and correlates of psychological distress and impaired generic health-related quality of life (HRQOL) in testicular cancer (TC) survivors.

Methods

Men who had completed active anti-cancer treatment for TC between 6 months and 5 years previously showing no evidence of recurrence were recruited from 14 Australian cancer centers from September 2009 to February 2011. Participants completed a self-report questionnaire measuring demographic, disease, and treatment information, psychological distress (i.e., depression, anxiety, and stress; DASS21), generic health-related quality of life (HRQOL; SF-36v2), TC-specific HRQOL (EORTC QLQ-TC26), coping (MAC), social support (DUFSS), and unmet needs (CaSUN).

Results

Of 486 eligible TC survivors, 244 (50.2 %) completed the questionnaire. Compared with normative data, TC survivors reported: small but statistically significant increases in mean levels of anxiety and depression; a greater prevalence of moderate to extremely severe anxiety (19 %) and depression (20 %); and significant deficits to mostly mental aspects of generic HRQOL. The most problematic TC-specific HRQOL issues (e.g., fear of recurrence) were also more mental than physical. In multiple regression analyses, the strongest correlates of psychological distress and impaired generic HRQOL were psychosocial (e.g., helpless/hopeless coping and lower social support) rather than disease or treatment factors.

Conclusions

Generally, TC survivors appear to experience mild psychological distress and HRQOL impairments, while a vulnerable subgroup experience more severe morbidity.

Implications for Cancer Survivors

There is a need to identify TC survivors at risk of poorer outcomes and for interventions to target the areas of greatest impairment (i.e., psychological distress and mental HRQOL).
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Cancer Incidence in Five Continents. Lyon: IARC. 2007. Cancer Incidence in Five Continents. Lyon: IARC. 2007.
2.
Zurück zum Zitat Haugnes HS, Bosl GJ, Boer H, et al. Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up. J Clin Oncol. 2012;30:3752–63.CrossRefPubMed Haugnes HS, Bosl GJ, Boer H, et al. Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up. J Clin Oncol. 2012;30:3752–63.CrossRefPubMed
3.
Zurück zum Zitat Fleer J, Hoekstra HJ, Sleijfer DT, et al. Quality of life of testicular cancer survivors and the relationship with sociodemographics, cancer-related variables, and life events. Support Care Cancer. 2006;14:251–9.CrossRefPubMed Fleer J, Hoekstra HJ, Sleijfer DT, et al. Quality of life of testicular cancer survivors and the relationship with sociodemographics, cancer-related variables, and life events. Support Care Cancer. 2006;14:251–9.CrossRefPubMed
4.
Zurück zum Zitat Kim C, McGlynn KA, McCorkle R, et al. Quality of life among testicular cancer survivors: a case-control study in the United States. Qual Life Res: Int J Qual Life Asp Treat Care Rehabil. 2011;20:1629–37.CrossRef Kim C, McGlynn KA, McCorkle R, et al. Quality of life among testicular cancer survivors: a case-control study in the United States. Qual Life Res: Int J Qual Life Asp Treat Care Rehabil. 2011;20:1629–37.CrossRef
5.
Zurück zum Zitat Joly F, Heron JF, Kalusinski L, et al. Quality of life in long-term survivors of testicular cancer: a population-based case-control study. J Clin Oncol. 2002;20:73–80.CrossRefPubMed Joly F, Heron JF, Kalusinski L, et al. Quality of life in long-term survivors of testicular cancer: a population-based case-control study. J Clin Oncol. 2002;20:73–80.CrossRefPubMed
6.
Zurück zum Zitat Gudbergsson SB, Fosså SD, Dahl AA. Are there sex differences in the work ability of cancer survivors? Norwegian experiences from the NOCWO study. Support Care Cancer. 2011;19:323–31.CrossRefPubMed Gudbergsson SB, Fosså SD, Dahl AA. Are there sex differences in the work ability of cancer survivors? Norwegian experiences from the NOCWO study. Support Care Cancer. 2011;19:323–31.CrossRefPubMed
7.
Zurück zum Zitat Rossen PB, Pedersen AF, Zachariae R, et al. Health-related quality of life in long-term survivors of testicular cancer. J Clin Oncol. 2009;27:5993–9.CrossRefPubMed Rossen PB, Pedersen AF, Zachariae R, et al. Health-related quality of life in long-term survivors of testicular cancer. J Clin Oncol. 2009;27:5993–9.CrossRefPubMed
8.
Zurück zum Zitat Pedersen AD, Rossen P, Mehlsen MY, et al. Long-term cognitive function following chemotherapy in patients with testicular cancer. J Int Neuropsychol Soc. 2009;15:296–301.CrossRefPubMed Pedersen AD, Rossen P, Mehlsen MY, et al. Long-term cognitive function following chemotherapy in patients with testicular cancer. J Int Neuropsychol Soc. 2009;15:296–301.CrossRefPubMed
9.
Zurück zum Zitat Dahl AA, Haaland CF, Mykletun A, et al. Study of anxiety disorder and depression in long-term survivors of testicular cancer. J Clin Oncol. 2005;23:2389–95.CrossRefPubMed Dahl AA, Haaland CF, Mykletun A, et al. Study of anxiety disorder and depression in long-term survivors of testicular cancer. J Clin Oncol. 2005;23:2389–95.CrossRefPubMed
10.
Zurück zum Zitat Skoogh J, Steineck G, Stierner U, et al. Testicular-cancer survivors experience compromised language following chemotherapy: findings in a Swedish population-based study 3-26 years after treatment. Acta Oncol. 2012;51:185–97.CrossRefPubMed Skoogh J, Steineck G, Stierner U, et al. Testicular-cancer survivors experience compromised language following chemotherapy: findings in a Swedish population-based study 3-26 years after treatment. Acta Oncol. 2012;51:185–97.CrossRefPubMed
11.
Zurück zum Zitat Fossa SD, Dahl AA, Loge JH. Fatigue, anxiety, and depression in long-term survivors of testicular cancer. J Clin Oncol. 2003;21:1249–54.CrossRefPubMed Fossa SD, Dahl AA, Loge JH. Fatigue, anxiety, and depression in long-term survivors of testicular cancer. J Clin Oncol. 2003;21:1249–54.CrossRefPubMed
12.
Zurück zum Zitat Mykletun A, Dahl AA, Haaland CF, et al. Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer. J Clin Oncol. 2005;23:3061–8.CrossRefPubMed Mykletun A, Dahl AA, Haaland CF, et al. Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer. J Clin Oncol. 2005;23:3061–8.CrossRefPubMed
13.
Zurück zum Zitat Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. J Am Med Assoc. 1995;273:59–65.CrossRef Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. J Am Med Assoc. 1995;273:59–65.CrossRef
14.
Zurück zum Zitat Smith AB, King M, Butow P, Grimison P, Olver I. Reduced quality of life in internet-panel controls. Epidemiology. 2013;24:462–3.CrossRef Smith AB, King M, Butow P, Grimison P, Olver I. Reduced quality of life in internet-panel controls. Epidemiology. 2013;24:462–3.CrossRef
15.
Zurück zum Zitat Smith AB, King M, Butow P, Olver I. A comparison of data quality and practicality of online versus postal questionnaires in a sample of testicular cancer survivors. Psychooncology. 2013;22:233–7.CrossRefPubMed Smith AB, King M, Butow P, Olver I. A comparison of data quality and practicality of online versus postal questionnaires in a sample of testicular cancer survivors. Psychooncology. 2013;22:233–7.CrossRefPubMed
16.
Zurück zum Zitat Smith A, King M, Butow P, et al. The prevalence and correlates of supportive care needs in testicular cancer survivors: a cross-sectional study. Psychooncology. 2013;22:2557–64.CrossRefPubMed Smith A, King M, Butow P, et al. The prevalence and correlates of supportive care needs in testicular cancer survivors: a cross-sectional study. Psychooncology. 2013;22:2557–64.CrossRefPubMed
17.
Zurück zum Zitat Lovibond SH, Lovibond PF. Manual for the depression anxiety stress scales. Secondth ed. Sydney: Psychology Foundation; 1995. Lovibond SH, Lovibond PF. Manual for the depression anxiety stress scales. Secondth ed. Sydney: Psychology Foundation; 1995.
18.
Zurück zum Zitat Ware Jr JE, Kosinski M, Bjorner JB, Turner-Bowker DM, Gandek B, Maruish ME. User’s manual for the SF-36v2 Health Survey. 2nd ed. Lincoln: Quality Metric Incorporated; 2007. Ware Jr JE, Kosinski M, Bjorner JB, Turner-Bowker DM, Gandek B, Maruish ME. User’s manual for the SF-36v2 Health Survey. 2nd ed. Lincoln: Quality Metric Incorporated; 2007.
19.
Zurück zum Zitat Holzner B, Efficace F, Basso U, et al. Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26. Qual Life Res. 2013;22:369–78.CrossRefPubMedPubMedCentral Holzner B, Efficace F, Basso U, et al. Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26. Qual Life Res. 2013;22:369–78.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Watson M, Greer S, Young J, Inayat Q, Burgess C, Robertson B. Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med. 1988;18:203–9.CrossRefPubMed Watson M, Greer S, Young J, Inayat Q, Burgess C, Robertson B. Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med. 1988;18:203–9.CrossRefPubMed
21.
Zurück zum Zitat Broadhead WE, Gehlbach SH, de Gruy FV, Kaplan BH. The Duke-UNC Functional Social Support Questionnaire. Measurement of social support in family medicine patients. Med Care. 1988;26:709–23.CrossRefPubMed Broadhead WE, Gehlbach SH, de Gruy FV, Kaplan BH. The Duke-UNC Functional Social Support Questionnaire. Measurement of social support in family medicine patients. Med Care. 1988;26:709–23.CrossRefPubMed
22.
Zurück zum Zitat Hodgkinson K, Butow P, Hunt GE, et al. The development and evaluation of a measure to assess cancer survivors’ unmet supportive care needs: the CaSUN (Cancer Survivors’ Unmet Needs measure). Psychooncology. 2007;16:796–804.CrossRefPubMed Hodgkinson K, Butow P, Hunt GE, et al. The development and evaluation of a measure to assess cancer survivors’ unmet supportive care needs: the CaSUN (Cancer Survivors’ Unmet Needs measure). Psychooncology. 2007;16:796–804.CrossRefPubMed
23.
Zurück zum Zitat Fayers PM, Curran D, Machin D. Incomplete quality of life data in randomized trials: missing items. Stat Med. 1998;17:679–96.CrossRefPubMed Fayers PM, Curran D, Machin D. Incomplete quality of life data in randomized trials: missing items. Stat Med. 1998;17:679–96.CrossRefPubMed
24.
Zurück zum Zitat Hawthorne G, Osborne RH, Taylor A, Sansoni J. The SF36 Version 2: critical analyses of population weights, scoring algorithms and population norms. Qual Life Res. 2007;16:661–73.CrossRefPubMed Hawthorne G, Osborne RH, Taylor A, Sansoni J. The SF36 Version 2: critical analyses of population weights, scoring algorithms and population norms. Qual Life Res. 2007;16:661–73.CrossRefPubMed
25.
Zurück zum Zitat Kutner MH, Nachtsheim C, Neter J. Applied linear regression models. McGraw-Hill/Irwin; 2004. Kutner MH, Nachtsheim C, Neter J. Applied linear regression models. McGraw-Hill/Irwin; 2004.
27.
Zurück zum Zitat Kessler RC, Wai TC, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617–27.CrossRefPubMedPubMedCentral Kessler RC, Wai TC, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617–27.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Fossa SD, Dahl AA. Short Form 36 and Hospital Anxiety and Depression Scale: a comparison based on patients with testicular cancer. J Psychosom Res. 2002;52:79–87.CrossRefPubMed Fossa SD, Dahl AA. Short Form 36 and Hospital Anxiety and Depression Scale: a comparison based on patients with testicular cancer. J Psychosom Res. 2002;52:79–87.CrossRefPubMed
30.
Zurück zum Zitat Rutskij R, Gaarden T, Bremnes R, et al. A study of coping in long-term testicular cancer survivors. Psychol Health Med. 2010;15:146–58.CrossRefPubMed Rutskij R, Gaarden T, Bremnes R, et al. A study of coping in long-term testicular cancer survivors. Psychol Health Med. 2010;15:146–58.CrossRefPubMed
31.
Zurück zum Zitat Johansson M, Rydén A, Finizia C. Mental adjustment to cancer and its relation to anxiety, depression, HRQL and survival in patients with laryngeal cancer—a longitudinal study. BMC Cancer. 2011;11. Johansson M, Rydén A, Finizia C. Mental adjustment to cancer and its relation to anxiety, depression, HRQL and survival in patients with laryngeal cancer—a longitudinal study. BMC Cancer. 2011;11.
32.
Zurück zum Zitat Simard S, Thewes B, Humphris G, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;1–23. Simard S, Thewes B, Humphris G, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;1–23.
33.
Zurück zum Zitat Paterson C, Jones M, Rattray J, Lauder W. Exploring the relationship between coping, social support and health-related quality of life for prostate cancer survivors: a review of the literature. Eur J Oncol Nurs. 2013;17:750–9.CrossRefPubMed Paterson C, Jones M, Rattray J, Lauder W. Exploring the relationship between coping, social support and health-related quality of life for prostate cancer survivors: a review of the literature. Eur J Oncol Nurs. 2013;17:750–9.CrossRefPubMed
34.
Zurück zum Zitat Jonker-Pool G, Van de Wiel HB, Hoekstra HJ, et al. Sexual functioning after treatment for testicular cancer—review and meta-analysis of 36 empirical studies between 1975-2000. Arch Sex Behav. 2001;30:55–74.CrossRefPubMed Jonker-Pool G, Van de Wiel HB, Hoekstra HJ, et al. Sexual functioning after treatment for testicular cancer—review and meta-analysis of 36 empirical studies between 1975-2000. Arch Sex Behav. 2001;30:55–74.CrossRefPubMed
35.
Zurück zum Zitat Steiner JF, Cavender TA, Nowels CT, et al. The impact of physical and psychosocial factors on work characteristics after cancer. Psychooncology. 2008;17:138–47.CrossRefPubMed Steiner JF, Cavender TA, Nowels CT, et al. The impact of physical and psychosocial factors on work characteristics after cancer. Psychooncology. 2008;17:138–47.CrossRefPubMed
36.
Zurück zum Zitat Pedersen AF, Rossen P, Olesen F, Von Der Maase H, Vedsted P. Fear of recurrence and causal attributions in long-term survivors of testicular cancer. Psychooncology. 2012;21:1222–8.CrossRefPubMed Pedersen AF, Rossen P, Olesen F, Von Der Maase H, Vedsted P. Fear of recurrence and causal attributions in long-term survivors of testicular cancer. Psychooncology. 2012;21:1222–8.CrossRefPubMed
37.
Zurück zum Zitat Skaali T, Fossa SD, Bremnes R, et al. Fear of recurrence in long-term testicular cancer survivors. Psycho-Oncology. 2009;18:580–8.CrossRefPubMed Skaali T, Fossa SD, Bremnes R, et al. Fear of recurrence in long-term testicular cancer survivors. Psycho-Oncology. 2009;18:580–8.CrossRefPubMed
38.
Zurück zum Zitat Lewis FM. The impact of cancer on the family: a critical analysis of the research literature. Patient Educ Couns. 1986;8:269–89.CrossRef Lewis FM. The impact of cancer on the family: a critical analysis of the research literature. Patient Educ Couns. 1986;8:269–89.CrossRef
39.
Zurück zum Zitat Fegg MJ, Gerl A, Vollmer TC, et al. Subjective quality of life and sexual functioning after germ-cell tumour therapy. Br J Cancer. 2003;89:2202–6.CrossRefPubMedPubMedCentral Fegg MJ, Gerl A, Vollmer TC, et al. Subjective quality of life and sexual functioning after germ-cell tumour therapy. Br J Cancer. 2003;89:2202–6.CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Kim C, McGlynn KA, McCorkle R, et al. Fertility among testicular cancer survivors: a case-control study in the US. J Cancer Survivorship. 2010;4:266–73.CrossRef Kim C, McGlynn KA, McCorkle R, et al. Fertility among testicular cancer survivors: a case-control study in the US. J Cancer Survivorship. 2010;4:266–73.CrossRef
41.
Zurück zum Zitat Greer S, Moorey S, Baruch JDR, et al. Adjuvant psychological therapy for patients with cancer: a prospective randomised trial. Br Med J. 1992;304:675–80.CrossRef Greer S, Moorey S, Baruch JDR, et al. Adjuvant psychological therapy for patients with cancer: a prospective randomised trial. Br Med J. 1992;304:675–80.CrossRef
42.
Zurück zum Zitat Gottlied BH, Wachala ED. Cancer support groups: a critical review of empirical studies. Psychooncology. 2007;16:379–400.CrossRef Gottlied BH, Wachala ED. Cancer support groups: a critical review of empirical studies. Psychooncology. 2007;16:379–400.CrossRef
43.
Zurück zum Zitat Rosenberg JP. Circles in the surf: Australian masculinity, mortality and grief. Crit Public Health. 2009;19:417–26.CrossRef Rosenberg JP. Circles in the surf: Australian masculinity, mortality and grief. Crit Public Health. 2009;19:417–26.CrossRef
44.
Zurück zum Zitat Griffiths KM, Farrer L, Christensen H. The efficacy of internet interventions for depression and anxiety disorders: a review of randomised controlled trials. Med J Aust. 2010;192:S4–11.PubMed Griffiths KM, Farrer L, Christensen H. The efficacy of internet interventions for depression and anxiety disorders: a review of randomised controlled trials. Med J Aust. 2010;192:S4–11.PubMed
Metadaten
Titel
The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study
verfasst von
Allan “Ben” Smith
Phyllis Butow
Ian Olver
Tim Luckett
Peter Grimison
Guy C. Toner
Martin R Stockler
Elizabeth Hovey
John Stubbs
Sandra Turner
George Hruby
Howard Gurney
Mahmood Alam
Keith Cox
Madeleine T. King
Publikationsdatum
01.04.2016
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 2/2016
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-015-0468-5

Weitere Artikel der Ausgabe 2/2016

Journal of Cancer Survivorship 2/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.